Top 40 Aprea investors
The most complete profiles first. Showing 40 of 41.
Andy SchwabVerified
Venture Capital, Founder, Private Equity Firm · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 57 more
Verified email available
Brian AtwoodVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsCybersecurityWomen FoundedPortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 63 more
Verified email available
Brian DanielsVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
Chris JacksonVerified
Venture Capital, Investor · United States
SeedHealth CareE-commerceWomen FoundedLife SciencePortfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more
Verified email available
Deborah PalestrantVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
Jason RuthVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
Lou TartagliaVerified
Venture Capital, Founder, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more
Verified email available
Rebecca ChenVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
Alexander MaywegVerified
Venture Capital, Private Equity Firm · Switzerland
Health CareGeneticsWomen FoundedLife SciencePortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more
Verified email available
Catherine PoulinVerified
Private Equity Firm, Investment Partner · Canada
Health CareInvestment ManagementLife ScienceEmerging MarketsPortfolio: HighLife, CurvaFix, Aprea, F2G and 19 more
Verified email available
Elliot EhrichVerified
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Jason DoddVerified
Venture Capital · United States
Health CareWomen FoundedLife ScienceSoftwarePortfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more
Contact details available
Jonathan WeissmanVerified
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Keith UnderwoodVerified
Venture Capital · United States
Health CareWomen FoundedLife ScienceSoftwarePortfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more
Verified email available
Paul StoneVerified
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
Rob FaulknerVerified
Hedge Fund, Venture Capital, Private Equity Firm · United States
Health CareHospitalsGeneticsWomen FoundedPortfolio: Lifesprout, Blueprint Medicines, OncoResponse, CorVent Medical and 73 more
Contact details available
Carlo Rizzuto
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 60 more
Contact details available
Charles Warden
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 61 more
Contact details available
Jamil M. Beg
Venture Capital, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
John Diekman
Venture Capital, Founder, Private Equity Firm · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more
Contact details available
Mason Freeman
Venture Capital, Investor · United States
SeedHealth CareHospitalsGeneticsLife SciencePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Mira Chaurushiya
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsAlternative MedicineAndroidPortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Per Samuelsson
Venture Capital, Private Equity Firm, Investor · Sweden
SeedHealth CareWomen FoundedLife ScienceSoftwarePortfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more
Contact details available
Ross Jaffe
Venture Capital, Investor · United States
Series BHealth CareGeneticsWomen FoundedLife SciencePortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 59 more
Contact details available
Scott Rocklage
Venture Capital, Founder, Private Equity Firm · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more
Contact details available
Staffan Lindstrand
Venture Capital, Private Equity Firm, Investor · Sweden
SeedHealth CareWomen FoundedLife ScienceSoftwarePortfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more
Contact details available
Steven WrightVerified
Venture Capital · United States
Health CareBiotechnologyClinical TrialsHealth DiagnosticsPortfolio: Aprea, MerLion Pharma, Modus Therapeutics, NovImmune and 4 more
Verified email available
Thomas WrightVerified
Venture Capital · United States
Health CareBiotechnologyClinical TrialsHealth DiagnosticsPortfolio: Aprea, MerLion Pharma, Modus Therapeutics, NovImmune and 4 more
Verified email available
Alain J. Gilbert
Private Equity Firm, Investment Partner · France
Health CareInvestment ManagementLife ScienceEmerging MarketsPortfolio: HighLife, CurvaFix, Aprea, F2G and 19 more
Contact details available
Beckie Robertson
Venture Capital, Private Equity Firm · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more
Contact details available
Bill Link
Venture Capital, Private Equity Firm · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more
Contact details available
Don Milder
Venture Capital, Private Equity Firm · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more
Contact details available
Gerard van Hamel Platerink
Hedge Fund, Venture Capital, Private Equity Firm · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Lifesprout, Blueprint Medicines, OncoResponse, CorVent Medical and 73 more
Contact details available
Joseph Victor
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Marc
Private Equity Firm, Investment Partner · Canada
Health CareInvestment ManagementLife ScienceEmerging MarketsPortfolio: HighLife, CurvaFix, Aprea, F2G and 19 more
Contact details available
Nikki Matthews
Venture Capital · United States
Health CareWomen FoundedLife ScienceSoftwarePortfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more
Contact details available
Paul Grayson
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more
Contact details available
Peter Kim
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
George Elish
Venture Capital · United States
Health CareBiotechnologyClinical TrialsHealth DiagnosticsPortfolio: Aprea, MerLion Pharma, Modus Therapeutics, NovImmune and 4 more
Contact details available
Jonathan Hepple
Venture Capital · United Kingdom
Health CareBiotechnologyClinical TrialsHealth DiagnosticsPortfolio: Aprea, MerLion Pharma, Modus Therapeutics, NovImmune and 4 more
Contact details available
See all 41 Aprea investors
Search, filter and unlock verified emails and LinkedIn profiles. Free to browse.
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Aprea investors are on Angel Roster?
Angel Roster lists 41 Aprea investors. 14 of them (34%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (38), Private Equity Firms (18) and Founder-Investors (4). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Aprea investors invest in?
Among those that list a stage, the most common are Seed (17) and Series B (1).
Where are Aprea investors based?
Most are based in the United States (33), Canada (3) and Sweden (2).
Which companies have Aprea investors backed?
The most-backed portfolio companies among them are Audentes Therapeutics (27), Nouscom (25), Ceterix Orthopaedics (25), Kinestral Technologies (25) and Crinetics Pharmaceuticals (25).
How do I contact Aprea investors?
Create a free Angel Roster account to search and filter all 41, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.